000 | 01835 a2200505 4500 | ||
---|---|---|---|
005 | 20250514053731.0 | ||
264 | 0 | _c20030429 | |
008 | 200304s 0 0 eng d | ||
022 | _a0014-2972 | ||
024 | 7 |
_a10.1046/j.1365-2362.2003.01105.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNaoumova, R P | |
245 | 0 | 0 |
_aTreatment with atorvastatin alters the ratio of interleukin-12/interleukin-10 gene expression [corrected]. _h[electronic resource] |
260 |
_bEuropean journal of clinical investigation _cJan 2003 |
||
300 |
_a88-91 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
650 | 0 | 4 | _aAtorvastatin |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperlipoproteinemia Type II _xblood |
650 | 0 | 4 |
_aInterleukin-10 _xbiosynthesis |
650 | 0 | 4 |
_aInterleukin-12 _xbiosynthesis |
650 | 0 | 4 | _aInterleukin-12 Subunit p35 |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMevalonic Acid _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aProtein Subunits _xbiosynthesis |
650 | 0 | 4 |
_aPyrroles _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aSingle-Blind Method |
700 | 1 | _aPatel, D D | |
700 | 1 | _aO'Neill, F H | |
700 | 1 | _aThompson, G R | |
700 | 1 | _aKnight, B L | |
773 | 0 |
_tEuropean journal of clinical investigation _gvol. 33 _gno. 1 _gp. 88-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2362.2003.01105.x _zAvailable from publisher's website |
999 |
_c12296548 _d12296548 |